Misplaced Pages

Carazolol

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound Pharmaceutical compound
Carazolol
Clinical data
AHFS/Drugs.comInternational Drug Names
ATCvet code
Identifiers
IUPAC name
  • 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.055.387 Edit this at Wikidata
Chemical and physical data
FormulaC18H22N2O2
Molar mass298.386 g·mol
3D model (JSmol)
SMILES
  • OC(CNC(C)C)COc3cccc2c3c1c(cccc1)2

Carazolol is a high affinity inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.

References

  1. Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.

External links


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: